PAPP, K. A.; MEROLA, J. F.; GOTTLIEB, A. B.; AL., E. Dual neutralization of IL-17A and IL-17F with bimekizumab improves quality of life in patients withmoderate-to-severe plaque psoriasis: results from a Phase 2b study and correlation with clinical response. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S92, 2018. DOI: 10.25251/skin.2.supp.93. Disponível em: https://www.jofskin.org/index.php/skin/article/view/489. Acesso em: 5 jul. 2022.